DETAILS, FICTION AND BLOCK PAIN RECEPTORS WITH PROLEVIATE

Owning discovered the palmitoylation motif of APLNR, we created a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation internet site in combination with morphine, can inhibit the event of NCP, which includes pain incidence, microglial activation, an